Cargando…
Inhibition of MLCK‑mediated migration and invasion in human endometriosis stromal cells by NF‑κB inhibitor DHMEQ
Endometriosis is initiated by the movement of endometrial cells in the uterus to the fallopian tubes, the ovaries and the peritoneal cavity after the shedding of the uterus lining. To cause endometriosis, it is often necessary for these endometrial cells to migrate, invade and grow at the secondary...
Autores principales: | Lin, Yinzhi, Kojima, Shiori, Ishikawa, Ayaka, Matsushita, Hiroshi, Takeuchi, Yuka, Mori, Yuki, Ma, Jun, Takeuchi, Kosei, Umezawa, Kazuo, Wakatsuki, Akihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308496/ https://www.ncbi.nlm.nih.gov/pubmed/37326118 http://dx.doi.org/10.3892/mmr.2023.13028 |
Ejemplares similares
-
Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review
por: Lin, Yinzhi, et al.
Publicado: (2018) -
Anticancer Activity of Novel NF-κB Inhibitor DHMEQ by Intraperitoneal Administration
por: Umezawa, Kazuo, et al.
Publicado: (2020) -
Inhibition of Canonical NF-κB Nuclear Localization by (−)-DHMEQ via Impairment of DNA Binding
por: Horie, Kana, et al.
Publicado: (2015) -
The designed NF-κB inhibitor, DHMEQ, inhibits KISS1R-mediated invasion and increases drug-sensitivity in mouse plasmacytoma SP2/0 cells
por: Lin, Yinzhi, et al.
Publicado: (2021) -
Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ
por: Ma, Jun, et al.
Publicado: (2021)